Asia-Pacific IBD market is estimated to grow significantly at a CAGR of around 5.5% during the forecast period. The major economies which are contributing to the market are China, India, and Japan. The market growth in China and India is attributed to the growing healthcare infrastructure due to substantial government spending in the healthcare sector. Rapid urbanization and changing eating habits are also supposed to grow the market substantially in the region. Japan contributes considerably in the IBD market due to growing awareness regarding IBD and the established healthcare industry. Along with these economies, Australia, Indonesia, and Thailand are other major countries with advanced healthcare facilities and projected to show a significant growth rate during the forecasted period.

Request a Free Sample of our Asia-Pacific Inflammatory Bowel Disease (IBD) Market: https://www.omrglobal.com/request-sample/asia-pacific-ibd-inflammatory-bowel-disease-market

Asia-Pacific IBD market is segmented on the basis of disease type, diagnostics, and therapeutics. Asia-Pacific IBD market is segmented on the basis of disease type into ulcerative colitis and Crohn’s disease. Crohn’s disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn’s disease than ulcerative colitis. On the basis of diagnostics, the market segmented into blood and stool, endoscopies, ultrasound, and X-rays. Endoscopy is a conventional diagnostic method that is widely being used for the diagnosis of IBD and having a considerable share in the market. The therapeutics segment is further segmented into anti-inflammatory drugs and surgery. There is a range of anti-inflammatory drugs used for the treatment of IBD, such as immunosuppressants (methotrexate, ciclosporin, and azathioprine), steroids and biological drugs. These are usually the first step in the treatment of IBD.

A full Report of Asia-Pacific Inflammatory Bowel Disease (IBD) Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-ibd-inflammatory-bowel-disease-market

Asia-Pacific Inflammatory Bowel Disease IBD Market Segmentation

By Disease Type

• Ulcerative Colitis
• Crohn’s Disease

By Diagnostics

• Blood and Stool Tests
• Endoscopies,
• Ultrasound
• X-Ray
• Asia-Pacific IBD Market by Therapeutics
• Surgery
• Anti- Inflammatory Drug Administration
• Steroids
• Immunosuppressant
• Biological Drugs
• Amino salicylates
• Others

Regional Analysis

• China
• India
• Japan
• Rest of Asia-Pacific

Company Profiles

• AbbVie Inc.
• Allergan, PLC
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Co. Ltd.
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• Mercator Pharmaceutical Solutions
• Pfizer Inc.
• RPG Life Sciences Ltd.
• Sanofi S.A.
• Takeda pharmaceutical Co., Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-ibd-inflammatory-bowel-disease-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 7803040404